In the present study, we provided evidence that SOX9 activates Wnt/beta-catenin pathway in human HCC cell lines; our gain/loss of SOX9 function experiments showed increase/decrease in nuclear-localized beta-catenin expression and its downstream targets including cyclin D1 and OPN. The gene discussed is CCND1; the disease is hepatocellular carcinoma.